[1]郑澹宁,孙国平.肝动脉化疗栓塞的肝癌患者生活质量调查研究[J].医学信息,2020,33(22):127-130.[doi:10.3969/j.issn.1006-1959.2020.22.036]
　ZHENG Dan-ning,SUN Guo-ping.Survey on the Quality of Life of Hepatocellular Cancer Patients Undergoing Transcatheter Arterial Chemoembolization[J].Medical Information,2020,33(22):127-130.[doi:10.3969/j.issn.1006-1959.2020.22.036]
点击复制

肝动脉化疗栓塞的肝癌患者生活质量调查研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年22期
页码:
127-130
栏目:
调查分析
出版日期:
2020-11-15

文章信息/Info

Title:
Survey on the Quality of Life of Hepatocellular Cancer Patients Undergoing Transcatheter Arterial Chemoembolization
文章编号:
1006-1959（2020）22-0127-04
作者:
郑澹宁; 孙国平
（安徽医科大学第一附属医院肿瘤科，安徽 合肥 230022）
Author(s):
ZHENG Dan-ning; SUN Guo-ping
(Department of Oncology,the First Affiliated Hospital of Anhui Medical University,Hefei 230022,Anhui,China)
关键词:
原发性肝癌; 肝动脉化疗栓塞; 生活质量
Keywords:
Hepatocellular cancer; Transcatheter arterial chemoembolization; Quality of life
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2020.22.036
文献标志码:
A
摘要:
目的 分析行肝动脉化疗栓塞（TACE）的原发性肝癌患者生活质量及影响因素。方法 选取2019年1~6月安徽医科大学第一附属医院行TACE的原发性肝癌患者130例，收集患者性别、年龄、肝炎病史、家庭支持、家庭月收入、文化程度、Child-Pugh分级、肝区疼痛及TNM临床分期，采用肝癌QOL量表（QOL-LC V2.0）评估其生活质量，分析影响患者生活质量的因素。结果 130例原发性肝癌患者TACE前生活质量（151.25±19.02）分，TACE后6周生活质量（150.05±24.28）分。不同性别及肝炎病史患者生活质量得分比较，差异无统计学意义（P＞0.05）；不同年龄、家庭支持、家庭月收入、文化程度、Child-Pugh分级、肝区疼痛、TNM临床分期及TACE前后患者生活质量得分比较，差异有统计学意义（P＜0.05）。多元线性回归分析显示，文化程度与生活质量正相关（β=3.425，P=0.045）；Child-Pugh分级和生活质量负相关（β=-4.613，P=0.031）。结论 原发性肝癌患者TACE后生活质量低于TACE前，其中年龄、文化程度、家庭月收入、家庭支持、Child-Pugh分级、肝区疼痛、TNM临床分期是生活质量影响因素。文化程度和生活质量正相关，Child-Pugh分级和生活质量负相关。
Abstract:
Objective To investigate and analyze the quality of life and influencing factors of patients withhepatocellular cancer undergoing transcatheter arterial chemoembolization (TACE). Methods Selecting 130 patients with primary liver cancer who underwent TACE in the First Affiliated Hospital of Anhui Medical University from January to June 2019. Collect the gender, age, hepatitis history, family support, family monthly income, education level, Child-Pugh classification, liver area pain and TNM clinical staging, the liver cancer QOL scale (QOL-LC V2.0) was used to assess the quality of life and analyze the factors affecting the quality of life of patients.Results The quality of life of 130 patients with primary liver cancer was (151.25±19.02) before TACE and (150.05±24.28) for 6 weeks after TACE. There was no statistically significant difference in the quality of life scores of patients with different genders and history of hepatitis (P>0.05); different ages, family support, family monthly income, education level, Child-Pugh classification, liver pain, TNM clinical stage and before and after TACEcomparison of patients’ quality of life scores showed statistical significance (P<0.05). Multiple linear regression analysis showed that education level was positively correlated with quality of life (β=3.425, P=0.045); Child-Pugh classification was negatively correlated with quality of life (β=-4.613, P=0.031).Conclusion The quality of life of patients with hepatocellular cancer after TACE is lower than before TACE. Age, educational level, family monthly income, family support, Child-Pugh classification, liver pain level, TNM stage are all factors that affect the quality of life of patients with hepatocellular cancer who undergo TACE. Education level is positively correlated with the quality of life score of patients with hepatocellular cancer who undergo TACE. Child-Pugh classification is negatively correlated with quality of life score in patients with hepatocellular cancer who undergo TACE.

参考文献/References:

[1]喻小静,蔡惠,李强,等.升荣口服液联合肝动脉介入化疗栓塞治疗原发性肝癌疗效及机制研究[J].中西医结合肝病杂志,2018,28(5):275-277.[2]冀春亮,陈正光.大肝癌的综合性微创介入治疗研究及预后分析[J].放射学实践,2018,33(3):308.[3]Wang Y,Ma L,Yuan ZH,et al.Percutaneous thermalablationcombined with TACE versus TACE monotherapy in thetreatment for liver cancer with hepatic vein tumor thrombus: A retrospective study[J].PLoS One,2018,13(9):e0201525．[4]Galle PR,Forner A,Llovet JM,et al.EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].J Hepatol,2018,69(1):182-236.[5]Vogel A,Cervantes A,Chau I,et al.Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol,2018,29(Suppl4):iv238-iv255.[6]Zhang Y,Zhang M,Chen M,et al.Association of Sustained Response DurationWith Survival After Conventional TransarterialChemoembolization in Patients With Hepatocellular Carcinoma[J].JAMA Netw Open,2018,1(6):e183213.[7]杜雪霏.近年来国内生命质量研究文献述评[J].产业与科技论坛,2015,14(2):122-123.[8]Tejeda-maldonado J,Garcia-juarez I,Aguirre-valadez J,et al.Diagnosis and treatment of hepatocellular carcinoma:An update[J].World J Hepatol,2015,7(3):362-376.[9]Kim JH,Yoon HK,Ko GY,et al.Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization[J].Radiology,2010,255(1):270-277.[10]Adam M,Jeffrey G,Cindy WD,et al.Systematic review of patient reported quality of life following stereotacticablative radiotherapy for primary and metastatic liver cancer[J].Radiat Oncol,2017,12(1):110.[11]应继荣,李雅方,傅萍.火针治疗中晚期肝癌疼痛的临床观察[J].实用中西医结合临床,2017,17(2):115-117.

相似文献/References:

[1]张 黎.中晚期原发性肝癌介入治疗的临床效果及对 肝功能的影响[J].医学信息,2018,31(09):20.[doi:10.3969/j.issn.1006-1959.2018.09.006]
　ZHANG Li.The Clinical Effect of Interventional Treatment of Primary Liver Cancer in Middle and Late Stage and its Effect on Liver Function[J].Medical Information,2018,31(22):20.[doi:10.3969/j.issn.1006-1959.2018.09.006]
[2]朱 瑞.血清AFP、CA19-9、CEA单项及三者联合检验对原发性肝癌早期诊断与治疗的意义对比[J].医学信息,2018,31(13):154.[doi:10.3969/j.issn.1006-1959.2018.13.047]
　ZHU Rui.Comparison of the Significance of Serum AFP,CA19-9,CEA Single and Combined the Three Methods Tests in the Early Diagnosis and Treatment of Primary Liver Cancer[J].Medical Information,2018,31(22):154.[doi:10.3969/j.issn.1006-1959.2018.13.047]
[3]侯宝松,王海峰,徐海晶,等.大黄蛰虫方合逍遥方加减对原发性肝细胞癌 TACE术后综合征影响[J].医学信息,2018,31(14):53.[doi:10.3969/j.issn.1006-1959.2018.14.017]
　HOU Bao-song,WANG Hai-feng,XU Hai-jing,et al.Effect of Rhubarb Aphid Fanghe Xiaoyaofang Decoction on Postoperative TACE Syndrome of Primary Hepatocellular Carcinoma[J].Medical Information,2018,31(22):53.[doi:10.3969/j.issn.1006-1959.2018.14.017]
[4]郑德仁.多排螺旋CT诊断肝血管瘤及肝脏肿瘤的临床价值分析[J].医学信息,2018,31(20):160.[doi:10.3969/j.issn.1006-1959.2018.20.050]
　ZHENG De-ren.Clinical Value of Multi-slice Spiral CT in Diagnosis of Hepatic Hemangioma and Liver Tumor[J].Medical Information,2018,31(22):160.[doi:10.3969/j.issn.1006-1959.2018.20.050]
[5]赵鱼扉,史政荣.肝脏储备功能临床应用研究[J].医学信息,2019,32(10):35.[doi:10.3969/j.issn.1006-1959.2019.10.013]
　ZHAO Yu-fei,SHI Zheng-rong.Clinical Application of Liver Reserve Function[J].Medical Information,2019,32(22):35.[doi:10.3969/j.issn.1006-1959.2019.10.013]
[6]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Medical Information,2019,32(22):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[7]邢时龙,淦 勤.原发性肝癌患者血清25-羟基维生素D3水平与免疫抑制因子IL-10的关系[J].医学信息,2020,33(01):101.[doi:10.3969/j.issn.1006-1959.2020.01.030]
　XING Shi-long,GAN Qin.Relationship Between Serum 25-hydroxyvitamin D3 Level and Immunosuppressive Factor IL-10 in Patients with Primary Liver Cancer[J].Medical Information,2020,33(22):101.[doi:10.3969/j.issn.1006-1959.2020.01.030]
[8]王瑞航,姚升娟,张 晨,等.肝动脉化疗栓塞介入术对原发性肝癌患者近期疗效及Child-Pugh分级的影响[J].医学信息,2020,33(17):101.[doi:10.3969/j.issn.1006-1959.2020.17.029]
　WANG Rui-hang,YAO Sheng-juan,ZHANG Chen,et al.Effect of Interventional Hepatic Artery Chemoembolization on the Short-term Efficacy and Child-Pugh Classification of Patients with Primary Liver Cancer[J].Medical Information,2020,33(22):101.[doi:10.3969/j.issn.1006-1959.2020.17.029]
[9]包学智.经肝动脉化疗栓塞联合射频消融术治疗中晚期原发性肝癌的效果[J].医学信息,2020,33(19):110.[doi:10.3969/j.issn.1006-1959.2020.19.033]
　BAO Xue-zhi.The Effect of Transhepatic Artery Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Advanced Primary Liver Cancer[J].Medical Information,2020,33(22):110.[doi:10.3969/j.issn.1006-1959.2020.19.033]
[10]郑春榕,阮清发.康氏学术流派在原发性肝癌治疗中的经验拾萃[J].医学信息,2021,34(05):169.[doi:10.3969/j.issn.1006-1959.2021.05.049]

更新日期/Last Update: 1900-01-01